Document Detail

Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure.
MedLine Citation:
PMID:  21437776     Owner:  NLM     Status:  Publisher    
PURPOSE: The pathogenesis of cardiovascular complications of obstructive sleep apnea syndrome (OSAS) can be explained by oxidative and carbonyl stress due to oxygenation and reoxygenation injury during sleep. This hypothesis has yet to be proved experimentally, although several clinical observations have found increased oxidative damage in plasma. Continuous positive airway pressure (CPAP) improves symptoms and prognosis of patients with OSAS. METHODS: Patients with confirmed SAS (n = 89) underwent polysomnography and received CPAP treatment. Plasma and saliva samples were taken before CPAP therapy as well as after 1 and 6 months of CPAP treatment. Selected markers of oxidative and carbonyl stress were measured in plasma and saliva, and their dynamics was statistically analyzed. RESULTS: Plasma levels of thiobarbituric acid reacting substances-a marker of lipoperoxidation-and advanced glycation end products (AGEs)-a marker of carbonyl stress-were decreased by the CPAP therapy. The decrease of AGEs and fructosamine was also found in saliva. Interestingly, no gender differences and no changes of antioxidant status measured as total antioxidant capacity and ferrous reducing ability were found in either of the samples. CONCLUSION: Previous findings of lowered plasma markers of oxidative stress were confirmed. Plasma AGEs were lowered by CPAP therapy. This is the first study analyzing markers of oxidative and carbonyl stress in saliva. Non-invasive sampling of saliva makes it a very interesting source of information for repeated monitoring of therapy success. Salivary AGEs and fructosamine as markers of carbonyl stress were decreased by the CPAP therapy and might therefore have potential informative value for clinical observations, as well as for the understanding of the pathogenesis of OSAS complications.
Peter Celec; Július Hodosy; Michal Behuliak; Roland Pálffy; Roman Gardlík; Lukáč Halčák; Imrich Mucska
Related Documents :
1573706 - Pharmacokinetics of spiramycin after intravenous, intramuscular and subcutaneous admini...
12220816 - Efficacy of pgf(2alpha) to synchronize estrus in water buffalo cows (bubalus bubalis) i...
1796676 - Origin and significance of acetylcholine and choline in plasma and serum from normal an...
9004476 - Antithrombin-iii activity in plasma of healthy and sick cattle.
650006 - Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
3945926 - Removal of mesenteric gastrinoma: a case report.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-26
Journal Detail:
Title:  Sleep & breathing = Schlaf & Atmung     Volume:  -     ISSN:  1522-1709     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9804161     Medline TA:  Sleep Breath     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Institute of Molecular Biomedicine, Comenius University, Sasinkova 4, 811 08, Bratislava, Slovakia,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Using multidimensional projection techniques for reaching a high distinguishing ability in biosensin...
Next Document:  Efficacy of rapid maxillary expansion in children with obstructive sleep apnea syndrome: 36 months ...